MedPath

Effect of Ozone Oil After Non-surgical Periodontal Treatment

Not Applicable
Recruiting
Conditions
Periodontal Diseases
Interventions
Drug: Control
Drug: test
Registration Number
NCT05838209
Lead Sponsor
Universidade Federal Fluminense
Brief Summary

The goal of this clinical trial is to evaluate the use of ozone oil as an adjunctive of non-surgical periodontal treatment (NSPT) on diabetics type 2 patients (DM2) compared to control group with chronic periodontal disease.

The principal question is to evaluate if the ozone oil could improve periodontal clinical parameters.

Thirty-two sites of 16 diabetics type 2 patients (DM2) with moderate to advanced periodontal disease containing two sites with periodontal pocket depth (PPD) of \> 5 mm were selected.

The treatment was distributed in 2 groups in the split mouth design: Control- scaling and root planing + saline solution (control) and Test - scaling and root planning + ozone oil

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Periodontitis
  • Systemic type 2 diabetes
Exclusion Criteria
  • Hypersensitivity to ozone oil
  • Osteoporosis types I and II
  • Alcoholism
  • Immunosuppressio
  • Pregnant and lactating
  • Physical/emotional stress drugs
  • Use of antibiotics, anti-inflammatories and hormone
  • Oral candidiasis
  • Received periodontal treatment in the last six months prior to the procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlControlScaling and root planing + saline solution gel (control) will be adminster at probing depth \> 5mm.
TesttestScaling and root planing + Ozone Oil will be adminster at probing depth \> 5mm.
Primary Outcome Measures
NameTimeMethod
Plaque Indexbaseline

Percentage

Probing Depthbaseline

mm

clinical attachment levelbaseline

mm

Gingival Indexbaseline

Percentage

Secondary Outcome Measures
NameTimeMethod
Gingival Index3 months

Percentage

Probing Depth3 months

mm

clinical attachment levels3 months

mm

Plaque Index3 months

Percentage

Trial Locations

Locations (1)

Gabriela Alessandra da Cruz Galhardo Camargo

🇧🇷

Nova Friburgo, RJ, Brazil

© Copyright 2025. All Rights Reserved by MedPath